BioLife Solutions - 27 Year Stock Price History | BLFS

Historical daily share price chart and data for BioLife Solutions since 1992 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for BioLife Solutions as of January 18, 2019 is 12.20.
BioLife Solutions Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 12.3192 12.0000 13.1400 10.9000 12.2000 1.41%
2018 11.5996 5.9600 25.4750 4.7330 12.0300 100.50%
2017 3.5120 1.6200 6.9000 1.6200 6.0000 272.60%
2016 1.7638 2.0500 2.3700 1.4500 1.6103 -25.79%
2015 2.0760 1.6400 2.7900 1.5000 2.1700 32.32%
2014 3.4332 8.4000 8.4000 1.6400 1.6400 -80.48%
2013 7.2089 4.7600 19.6000 3.5000 8.4000 76.47%
2012 2.0098 0.7000 6.3000 0.5600 4.7600 580.00%
2011 1.0228 1.2600 1.5400 0.2800 0.7000 -16.67%
2010 1.0978 1.5400 1.8200 0.5600 0.8400 -45.45%
2009 1.5167 0.5600 2.9400 0.4200 1.5400 266.67%
2008 0.7747 0.8400 1.2600 0.2800 0.4200 -50.00%
2007 1.4162 1.1200 2.3800 0.7000 0.8400 -14.29%
2006 1.1579 1.6800 1.6800 0.8400 0.9800 -41.67%
2005 1.7006 0.8400 3.5000 0.8400 1.6800 33.33%
2004 1.9344 1.5400 3.3600 0.9800 1.2600 -18.18%
2003 1.7944 1.6800 3.0800 1.1200 1.5400 -8.33%
2002 2.1189 2.8000 4.0600 1.2600 1.6800 -42.86%
2001 4.3767 7.0000 9.6600 0.7000 2.9400 -58.00%
2000 10.5867 2.6600 36.8200 2.3800 7.0000 212.50%
1999 4.9311 1.1200 12.7400 0.8400 2.2400 100.00%
1998 2.6331 3.0800 6.5800 0.8400 1.1200 -57.89%
1997 5.6028 4.7600 10.0800 2.2400 2.6600 -44.12%
1996 25.2937 31.5000 46.3400 3.9200 4.7600 -83.00%
1995 40.5606 42.0000 51.6600 28.0000 28.0000 -33.33%
1994 44.1133 56.0000 65.6600 26.3200 42.0000 -25.00%
1993 81.1618 119.0000 119.0000 43.8200 56.0000 -54.29%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.226B $0.011B
BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $125.437B 25.42
Medtronic (MDT) Ireland $117.248B 17.53
Stryker (SYK) United States $62.695B 23.63
Boston Scientific (BSX) United States $52.155B 26.36
Baxter (BAX) United States $37.585B 24.27
Zimmer Biomet Holdings (ZBH) United States $21.487B 13.93
ResMed (RMD) United States $16.792B 32.02
Smith & Nephew SNATS (SNN) United Kingdom $16.606B 0.00
Canopy Growth (CGC) Canada $10.104B 0.00
Bio-Rad Laboratories (BIO) United States $7.180B 45.91
Hill-Rom Holdings (HRC) United States $6.608B 20.68
Aurora Cannabis (ACB) Canada $6.428B 33.90
Perrigo (PRGO) Ireland $6.245B 9.48
Haemonetics (HAE) United States $5.216B 45.87
ICU Medical (ICUI) United States $4.878B 27.18
Insulet (PODD) United States $4.428B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.141B 0.00
Agios Pharmaceuticals (AGIO) United States $3.252B 0.00
Neogen (NEOG) United States $3.150B 48.38
Hutchison China MediTech (HCM) China $2.945B 0.00
National Vision Holdings (EYE) United States $2.566B 49.63
NuVasive (NUVA) United States $2.469B 22.98
Quidel (QDEL) United States $2.084B 27.17
NxStage Medical (NXTM) United States $1.901B 0.00
Aphria (APHA) $1.668B 74.22
Phibro Animal Health (PAHC) United States $1.294B 18.32
AtriCure (ATRC) United States $1.222B 0.00
VAREX IMAGING (VREX) United States $1.060B 21.23
Cardiovascular Systems (CSII) United States $1.013B 1457.00
PetIQ (PETQ) United States $0.781B 20.25
Cerus (CERS) United States $0.771B 0.00
OraSure Technologies (OSUR) United States $0.747B 42.03
Meridian Bioscience (VIVO) United States $0.713B 22.73
Eagle Pharmaceuticals (EGRX) United States $0.662B 21.24
Omeros (OMER) United States $0.658B 0.00
Surmodics (SRDX) United States $0.642B 97.18
Lantheus Holdings (LNTH) United States $0.637B 19.73
NanoString Technologies (NSTG) United States $0.624B 0.00
MacroGenics (MGNX) United States $0.520B 0.00
Quanterix (QTRX) United States $0.467B 0.00
LeMaitre Vascular (LMAT) United States $0.458B 22.48
Owens & Minor (OMI) United States $0.453B 5.12
Evolus (EOLS) United States $0.436B 0.00
TG Therapeutics (TGTX) United States $0.375B 0.00
Insys Therapeutics (INSY) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.322B 20.85
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.279B 0.00
Bovie Medical (APYX) United States $0.278B 0.00
Vapotherm (VAPO) United States $0.273B 0.00
Cytosorbents (CTSO) United States $0.244B 0.00
Rockwell Medical (RMTI) United States $0.198B 0.00
Fonar (FONR) United States $0.139B 7.00
Chimerix (CMRX) United States $0.137B 0.00
Surface Oncology (SURF) United States $0.136B 0.00
Chembio Diagnostics (CEMI) United States $0.121B 0.00
United-Guardian (UG) United States $0.090B 18.85
Female Health (VERU) United States $0.084B 0.00
Trinity Biotech (TRIB) Ireland $0.065B 18.07
Oramed Pharmaceuticals (ORMP) United States $0.059B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Neurotrope (NTRP) United States $0.031B 0.00
Capricor Therapeutics (CAPR) United States $0.021B 0.00
Senestech (SNES) United States $0.019B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00